ArticleActa pharmacologica Sinica2022

Selective EZH2 inhibitor zld1039 alleviates inflammation in cisplatin-induced acute kidney injury partially by enhancing RKIP and suppressing NF-κB p65 pathway.

Li Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.